Results 141 to 150 of about 167,641 (233)

Therapeutic Effects of Quetiapine and 5-HT_1A Receptor Agonism on Hyperactivity in Dopamine-Deficient Mice. [PDF]

Int J Mol Sci, 2022
Ochiai Y, Fujita M, Hagino Y, Kobayashi K, Okiyama R, Takahashi K, Ikeda K.   +6 more
europepmc   +1 more source

Prefrontal Cortex 5-HT1A Receptor-Coupled Inwardly Rectifying Potassium Channels Decreased Seizure Susceptibility in Rat Models With Autism Spectrum Disorder. [PDF]

Neural Plast
Li Z, Sun Y, Huo X, Ren X, Ding N, Qian X, Li A, Sun T.   +7 more
europepmc   +1 more source

Is temporal lobe epilepsy a progressive disease? Insights from a 5-HT_1A receptor partial volume correction study. [PDF]

Epilepsy Res
Giovacchini G, Marciano A, Agrawal S, Theodore WH.   +3 more
europepmc   +1 more source

Multimodal imaging study of the 5-HT_1A receptor biased agonist, NLX-112, in a model of L-DOPA-induced dyskinesia. [PDF]

Neuroimage Clin, 2023
Chaib S, Vidal B, Bouillot C, Depoortere R, Newman-Tancredi A, Zimmer L, Levigoureux E.   +6 more
europepmc   +1 more source

Cardamonin Modulates Neuropathic Pain through the Possible Involvement of Serotonergic 5-HT1A Receptor Pathway in CCI-Induced Neuropathic Pain Mice Model. [PDF]

Molecules, 2021
Kaswan NK, Mohammed Izham NAB, Tengku Mohamad TAS, Sulaiman MR, Perimal EK.   +4 more
europepmc   +1 more source

The C/C Genotype of the C-1019G (rs6295) Polymorphism of the 5-HT1A Receptor Gene Is Associated with Lower Susceptibility to Depressive Symptoms in a Rural Population in Mexico. [PDF]

Neurol Int
Hernandez-Mixteco M, Valenzuela OL, Balderas-Vazquez CL, Castillo-Juárez P, Rivera-Gutiérrez S, García-Reyes RL, Cornejo-Estudillo G, Soria-Herrera RJ, León-Juárez M, Helguera-Repetto AC, Valencia-Trujillo D, Campos-Peña V, Garcia-Montalvo EA, Cerna-Cortés JF.   +13 more
europepmc   +1 more source

Correction To: TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT_1A receptor agonist SEP- 363856. [PDF]

Neuropsychopharmacology, 2023
Saarinen M, Mantas I, Flais I, Ågren R, Sahlholm K, Millan MJ, Svenningsson P.   +6 more
europepmc   +1 more source

The 5-HT_1A receptor biased agonists, NLX-204 and NLX-101, display ketamine-like RAAD and anti-TRD activities in rat CMS models. [PDF]

Psychopharmacology (Berl), 2023
Papp M, Gruca P, Lason M, Litwa E, Newman-Tancredi A, Depoortère R.   +5 more
europepmc   +1 more source

Activation of the 5-HT1A Receptor by Eltoprazine Restores Mitochondrial and Motor Deficits in a Drosophila Model of Fragile X Syndrome. [PDF]

Int J Mol Sci
Vannelli A, Mariano V, Bagni C, Kanellopoulos AK.   +3 more
europepmc   +1 more source

TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT_1A receptor agonist SEP-383856. [PDF]

Neuropsychopharmacology, 2022
Saarinen M, Mantas I, Flais I, Ågren R, Sahlholm K, Millan MJ, Svenningsson P.   +6 more
europepmc   +1 more source